- Home
- FOA vs INMB Comparison
FOA vs INMB Comparison
Compare FOA & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- INMB
- Stock Information
- Founded
- FOA 2013
- INMB 2015
- Country
- FOA United States
- INMB United States
- Employees
- FOA N/A
- INMB N/A
- Industry
- FOA Finance Companies
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- FOA Finance
- INMB Health Care
- Exchange
- FOA Nasdaq
- INMB Nasdaq
- Market Cap
- FOA 119.4M
- INMB 123.0M
- IPO Year
- FOA N/A
- INMB 2019
- Fundamental
- Price
- FOA $10.25
- INMB $5.46
- Analyst Decision
- FOA Strong Buy
- INMB Buy
- Analyst Count
- FOA 2
- INMB 1
- Target Price
- FOA $17.00
- INMB $22.00
- AVG Volume (30 Days)
- FOA 40.7K
- INMB 362.7K
- Earning Date
- FOA 11-05-2024
- INMB 10-30-2024
- Dividend Yield
- FOA N/A
- INMB N/A
- EPS Growth
- FOA N/A
- INMB N/A
- EPS
- FOA N/A
- INMB N/A
- Revenue
- FOA $359,013,000.00
- INMB $85,000.00
- Revenue This Year
- FOA N/A
- INMB N/A
- Revenue Next Year
- FOA N/A
- INMB N/A
- P/E Ratio
- FOA $7.76
- INMB N/A
- Revenue Growth
- FOA 540.89
- INMB N/A
- 52 Week Low
- FOA $4.10
- INMB $4.81
- 52 Week High
- FOA $14.31
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- FOA 51.20
- INMB 44.41
- Support Level
- FOA $9.79
- INMB $5.09
- Resistance Level
- FOA $12.33
- INMB $5.73
- Average True Range (ATR)
- FOA 1.00
- INMB 0.32
- MACD
- FOA -0.24
- INMB 0.09
- Stochastic Oscillator
- FOA 5.80
- INMB 69.52
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to an range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.